US FDA, Sponsors Eye Best Practices For Virtual AdComms

Agency has created a centralized team to help review divisions with virtual advisory committee preparations and is trying to notify sponsors earlier in the review process about the need for a panel; sponsors cite importance of having a back channel of communications so team members can communicate with each other while an AdComm is underway.

BEST PRACTICE chart with keywords and icons on screen
FDA and sponsors are developing best practices for virtual advisory committee meetings. • Source: Shutterstock

With no end in sight to the COVID-19 pandemic, the US Food and Drug Administration is planning for an extended run of virtual advisory committee meetings.

The Center for Drug Evaluation and Research has created an internal team dedicated to working on virtual AdComms and sharing best practices among review divisions

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America